TY - JOUR AU - Li, C. I. AU - Daling, J. R. AU - Malone, K. E. PY - 2005 DA - 2005// TI - Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001 JO - Cancer Epidemiol Biomarkers Prev VL - 14 UR - https://doi.org/10.1158/1055-9965.EPI-04-0849 DO - 10.1158/1055-9965.EPI-04-0849 ID - Li2005 ER - TY - JOUR AU - Weaver, D. L. AU - Rosenberg, R. D. AU - Barlow, W. E. AU - Ichikawa, L. AU - Carney, P. A. AU - Kerlikowske, K. AU - Buist, D. S. AU - Geller, B. M. AU - Key, C. R. AU - Maygarden, S. J. AU - Ballard-Barbash, R. PY - 2006 DA - 2006// TI - Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography JO - Cancer VL - 106 UR - https://doi.org/10.1002/cncr.21652 DO - 10.1002/cncr.21652 ID - Weaver2006 ER - TY - JOUR AU - Solin, L. J. AU - Fourquet, A. AU - Vicini, F. A. AU - Taylor, M. AU - Olivotto, I. A. AU - Haffty, B. AU - Strom, E. A. AU - Pierce, L. J. AU - Marks, L. B. AU - Bartelink, H. AU - McNeese, M. D. AU - Jhingran, A. AU - Wai, E. AU - Bijker, N. AU - Campana, F. AU - Hwang, W. T. PY - 2005 DA - 2005// TI - Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20886 DO - 10.1002/cncr.20886 ID - Solin2005 ER - TY - JOUR AU - Vicini, F. A. AU - Recht, A. PY - 2002 DA - 2002// TI - Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.07.137 DO - 10.1200/JCO.2002.07.137 ID - Vicini2002 ER - TY - JOUR AU - van de Vijver, M. J. PY - 2005 DA - 2005// TI - Biological variables and prognosis of DCIS JO - Breast VL - 14 UR - https://doi.org/10.1016/j.breast.2005.08.027 DO - 10.1016/j.breast.2005.08.027 ID - van de Vijver2005 ER - TY - JOUR AU - Toikkanen, S. AU - Helin, H. AU - Isola, J. AU - Joensuu, H. PY - 1992 DA - 1992// TI - Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30 year follow-up. JO - 10 VL - 10 ID - Toikkanen1992 ER - TY - JOUR AU - Provenzano, E. AU - Hopper, J. L. AU - Giles, G. G. AU - Marr, G. AU - Venter, D. J. AU - Armes, J. E. PY - 2003 DA - 2003// TI - Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast JO - Eur J Cancer VL - 39 UR - https://doi.org/10.1016/S0959-8049(02)00666-4 DO - 10.1016/S0959-8049(02)00666-4 ID - Provenzano2003 ER - TY - JOUR AU - Claus, E. B. AU - Chu, P. AU - Howe, C. L. AU - Davison, T. L. AU - Stern, D. F. AU - Carter, D. AU - DiGiovanna, M. P. PY - 2001 DA - 2001// TI - Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors JO - Exp Mol Pathol VL - 70 UR - https://doi.org/10.1006/exmp.2001.2366 DO - 10.1006/exmp.2001.2366 ID - Claus2001 ER - TY - JOUR AU - Latta, E. K. AU - Tjan, S. AU - Parkes, R. K. AU - O'Malley, F. P. PY - 2002 DA - 2002// TI - The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast JO - Mod Pathol VL - 15 UR - https://doi.org/10.1097/01.MP.0000038462.62634.B1 DO - 10.1097/01.MP.0000038462.62634.B1 ID - Latta2002 ER - TY - JOUR AU - Hoque, A. AU - Sneige, N. AU - Sahin, A. A. AU - Menter, D. G. AU - Bacus, J. W. AU - Hortobagyi, G. N. AU - Lippman, S. M. PY - 2002 DA - 2002// TI - Her-2/neu gene amplification in ductal carcinoma in situ of the breast JO - Cancer Epidemiol Biomarkers Prev VL - 11 ID - Hoque2002 ER - TY - JOUR AU - Keyomarsi, K. AU - O'Leary, N. AU - Molnar, G. AU - Lees, E. AU - Fingert, H. J. AU - Pardee, A. B. PY - 1994 DA - 1994// TI - Cyclin E, a potential prognostic marker for breast cancer JO - Cancer Res VL - 54 ID - Keyomarsi1994 ER - TY - JOUR AU - Wright, C. AU - Nicholson, S. AU - Angus, B. AU - Sainsbury, J. R. AU - Farndon, J. AU - Cairns, J. AU - Harris, A. L. AU - Horne, C. H. PY - 1992 DA - 1992// TI - Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer JO - Br J Cancer VL - 65 UR - https://doi.org/10.1038/bjc.1992.22 DO - 10.1038/bjc.1992.22 ID - Wright1992 ER - TY - JOUR AU - Varley, J. M. AU - Swallow, J. E. AU - Brammar, W. J. AU - Whittaker, J. L. AU - Walker, R. A. PY - 1987 DA - 1987// TI - Alerations to either c-erbB-s (neu) or c-myc protooncogenes in breast carcinoma correlate with poor short term prognosis. JO - Oncog VL - 1 ID - Varley1987 ER - TY - JOUR AU - Elledge, R. M. AU - Allred, D. C. PY - 1998 DA - 1998// TI - Prognostic and predictive value of p53 and p21 in breast cancer JO - Breast Cancer Res Treat VL - 52 UR - https://doi.org/10.1023/A:1006163101948 DO - 10.1023/A:1006163101948 ID - Elledge1998 ER - TY - JOUR AU - Schmid, B. C. AU - Rudas, M. AU - Rezniczek, G. A. AU - Leodolter, S. AU - Zeillinger, R. PY - 2004 DA - 2004// TI - CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia JO - Breast Cancer Res Treat VL - 84 UR - https://doi.org/10.1023/B:BREA.0000019962.18922.87 DO - 10.1023/B:BREA.0000019962.18922.87 ID - Schmid2004 ER - TY - JOUR AU - Lebeau, A. AU - Unholzer, A. AU - Amann, G. AU - Kronawitter, M. AU - Bauerfeind, I. AU - Sendelhofert, A. AU - Iff, A. AU - Lohrs, U. PY - 2003 DA - 2003// TI - EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast JO - Breast Cancer Res Treat VL - 79 UR - https://doi.org/10.1023/A:1023958324448 DO - 10.1023/A:1023958324448 ID - Lebeau2003 ER - TY - JOUR AU - Chasle, J. AU - Delozier, T. AU - Denoux, Y. AU - Marnay, J. AU - Michels, J. J. PY - 2003 DA - 2003// TI - Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study JO - Eur J Cancer VL - 39 UR - https://doi.org/10.1016/S0959-8049(02)00774-8 DO - 10.1016/S0959-8049(02)00774-8 ID - Chasle2003 ER - TY - JOUR AU - Perrone, G. AU - Santini, D. AU - Vincenzi, B. AU - Zagami, M. AU - La Cesa, A. AU - Bianchi, A. AU - Altomare, V. AU - Primavera, A. AU - Battista, C. AU - Vetrani, A. AU - Tonini, G. AU - Rabitti, C. PY - 2005 DA - 2005// TI - COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features JO - Histopathology VL - 46 UR - https://doi.org/10.1111/j.1365-2559.2005.02132.x DO - 10.1111/j.1365-2559.2005.02132.x ID - Perrone2005 ER - TY - JOUR AU - Half, E. AU - Tang, X. M. AU - Gwyn, K. AU - Sahin, A. AU - Wathen, K. AU - Sinicrope, F. A. PY - 2002 DA - 2002// TI - Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ JO - Cancer Res VL - 62 ID - Half2002 ER - TY - JOUR AU - Tan, K. B. AU - Yong, W. P. AU - Putti, T. C. PY - 2004 DA - 2004// TI - Cyclooxygenase-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast JO - Histopathology VL - 44 UR - https://doi.org/10.1111/j.1365-2559.2004.01774.x DO - 10.1111/j.1365-2559.2004.01774.x ID - Tan2004 ER - TY - JOUR AU - Fajas, L. AU - Debril, M. B. AU - Auwerx, J. PY - 2001 DA - 2001// TI - Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis JO - J Mol Endocrinol VL - 27 UR - https://doi.org/10.1677/jme.0.0270001 DO - 10.1677/jme.0.0270001 ID - Fajas2001 ER - TY - JOUR AU - Murphy, G. J. AU - Holder, J. C. PY - 2000 DA - 2000// TI - PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer JO - Trends Pharmacol Sci VL - 21 UR - https://doi.org/10.1016/S0165-6147(00)01559-5 DO - 10.1016/S0165-6147(00)01559-5 ID - Murphy2000 ER - TY - JOUR AU - Page, D. L. AU - Lagios, M. D. PY - 1994 DA - 1994// TI - Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast JO - Cancer Lett VL - 86 UR - https://doi.org/10.1016/0304-3835(94)90173-2 DO - 10.1016/0304-3835(94)90173-2 ID - Page1994 ER - TY - JOUR AU - Kallioniemi, O. P. AU - Wagner, U. AU - Kononen, J. AU - Sauter, G. PY - 2001 DA - 2001// TI - Tissue microarray technology for high-throughput molecular profiling of cancer JO - Hum Mol Genet VL - 10 UR - https://doi.org/10.1093/hmg/10.7.657 DO - 10.1093/hmg/10.7.657 ID - Kallioniemi2001 ER - TY - JOUR AU - Wulfing, P. AU - Diallo, R. AU - Muller, C. AU - Wulfing, C. AU - Poremba, C. AU - Heinecke, A. AU - Rody, A. AU - Greb, R. R. AU - Bocker, W. AU - Kiesel, L. PY - 2003 DA - 2003// TI - Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis JO - J Cancer Res Clin Oncol VL - 129 UR - https://doi.org/10.1007/s00432-003-0459-1 DO - 10.1007/s00432-003-0459-1 ID - Wulfing2003 ER - TY - JOUR AU - Papadaki, I. AU - Mylona, E. AU - Giannopoulou, I. AU - Markaki, S. AU - Keramopoulos, A. AU - Nakopoulou, L. PY - 2005 DA - 2005// TI - PPARgamma expression in breast cancer: clinical value and correlation with ERbeta JO - Histopathology VL - 46 UR - https://doi.org/10.1111/j.1365-2559.2005.02056.x DO - 10.1111/j.1365-2559.2005.02056.x ID - Papadaki2005 ER - TY - JOUR AU - Fritah, A. AU - Saucier, C. AU - Mester, J. AU - Redeuilh, G. AU - Sabbah, M. PY - 2005 DA - 2005// TI - p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha JO - Mol Cell Biol VL - 25 UR - https://doi.org/10.1128/MCB.25.6.2419-2430.2005 DO - 10.1128/MCB.25.6.2419-2430.2005 ID - Fritah2005 ER - TY - JOUR AU - Altucci, L. AU - Addeo, R. AU - Cicatiello, L. AU - Dauvois, S. AU - Parker, M. G. AU - Truss, M. AU - Beato, M. AU - Sica, V. AU - Bresciani, F. AU - Weisz, A. PY - 1996 DA - 1996// TI - 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells JO - Oncogene VL - 12 ID - Altucci1996 ER - TY - JOUR AU - Barnes, N. AU - Haywood, P. AU - Flint, P. AU - Knox, W. F. AU - Bundred, N. J. PY - 2006 DA - 2006// TI - Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6602932 DO - 10.1038/sj.bjc.6602932 ID - Barnes2006 ER - TY - JOUR AU - Singh, B. AU - Berry, J. A. AU - Shoher, A. AU - Ramakrishnan, V. AU - Lucci, A. PY - 2005 DA - 2005// TI - COX-2 overexpression increases motility and invasion of breast cancer cells JO - Int J Oncol VL - 26 ID - Singh2005 ER - TY - JOUR AU - Boland, G. P. AU - Butt, I. S. AU - Prasad, R. AU - Knox, W. F. AU - Bundred, N. J. PY - 2004 DA - 2004// TI - COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ JO - Br J Cancer VL - 90 UR - https://doi.org/10.1038/sj.bjc.6601534 DO - 10.1038/sj.bjc.6601534 ID - Boland2004 ER - TY - JOUR AU - Ristimaki, A. AU - Sivula, A. AU - Lundin, J. AU - Lundin, M. AU - Salminen, T. AU - Haglund, C. AU - Joensuu, H. AU - Isola, J. PY - 2002 DA - 2002// TI - Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer JO - Cancer Res VL - 62 ID - Ristimaki2002 ER - TY - JOUR AU - Costa, C. AU - Soares, R. AU - Reis-Filho, J. S. AU - Leitao, D. AU - Amendoeira, I. AU - Schmitt, F. C. PY - 2002 DA - 2002// TI - Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer JO - J Clin Pathol VL - 55 UR - https://doi.org/10.1136/jcp.55.6.429 DO - 10.1136/jcp.55.6.429 ID - Costa2002 ER - TY - JOUR AU - O'Connor, J. K. AU - Avent, J. AU - Lee, R. J. AU - Fischbach, J. AU - Gaffney, D. K. PY - 2004 DA - 2004// TI - Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy JO - Int J Radiat Oncol Biol Phys VL - 58 UR - https://doi.org/10.1016/j.ijrobp.2003.08.032 DO - 10.1016/j.ijrobp.2003.08.032 ID - O'Connor2004 ER - TY - JOUR AU - Dannenberg, A. J. AU - Howe, L. R. PY - 2003 DA - 2003// TI - The role of COX-2 in breast and cervical cancer JO - Prog Exp Tumor Res VL - 37 UR - https://doi.org/10.1159/000071368 DO - 10.1159/000071368 ID - Dannenberg2003 ER - TY - JOUR AU - Kulkarni, S. AU - Rader, J. S. AU - Zhang, F. AU - Liapis, H. AU - Koki, A. T. AU - Masferrer, J. L. AU - Subbaramaiah, K. AU - Dannenberg, A. J. PY - 2001 DA - 2001// TI - Cyclooxygenase-2 is overexpressed in human cervical cancer JO - Clin Cancer Res VL - 7 ID - Kulkarni2001 ER - TY - JOUR AU - Arun, B. AU - Goss, P. PY - 2004 DA - 2004// TI - The role of COX-2 inhibition in breast cancer treatment and prevention JO - Semin Oncol VL - 31 UR - https://doi.org/10.1053/j.seminoncol.2004.03.042 DO - 10.1053/j.seminoncol.2004.03.042 ID - Arun2004 ER - TY - JOUR AU - Brueggemeier, R. W. AU - Diaz-Cruz, E. S. PY - 2006 DA - 2006// TI - Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches JO - Minerva Endocrinol VL - 31 ID - Brueggemeier2006 ER - TY - JOUR AU - Solin, L. J. AU - Fourquet, A. AU - Vicini, F. A. AU - Haffty, B. AU - Taylor, M. AU - McCormick, B. AU - McNeese, M. AU - Pierce, L. J. AU - Landmann, C. AU - Olivotto, I. A. AU - Borger, J. AU - Kim, J. AU - de la, R. A. AU - Schultz, D. J. PY - 2001 DA - 2001// TI - Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status JO - Int J Radiat Oncol Biol Phys VL - 50 UR - https://doi.org/10.1016/S0360-3016(01)01517-6 DO - 10.1016/S0360-3016(01)01517-6 ID - Solin2001 ER - TY - JOUR AU - Cutuli, B. AU - Cohen-Solal-le, N. C. AU - de, L. B. AU - Mignotte, H. AU - Fichet, V. AU - Fay, R. AU - Servent, V. AU - Giard, S. AU - Charra-Brunaud, C. AU - Lemanski, C. AU - Auvray, H. AU - Jacquot, S. AU - Charpentier, J. C. PY - 2002 DA - 2002// TI - Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience JO - Int J Radiat Oncol Biol Phys VL - 53 UR - https://doi.org/10.1016/S0360-3016(02)02834-1 DO - 10.1016/S0360-3016(02)02834-1 ID - Cutuli2002 ER - TY - JOUR AU - Subbaramaiah, K. AU - Norton, L. AU - Gerald, W. AU - Dannenberg, A. J. PY - 2002 DA - 2002// TI - Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3 JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M111415200 DO - 10.1074/jbc.M111415200 ID - Subbaramaiah2002 ER - TY - CHAP AU - Schmitz, K. J. AU - Callies, R. AU - Wohlschlager, J. AU - Kimmig, R. AU - Otterbach, F. AU - Bohr, J. AU - Lee, H. S. AU - Takeda, A. AU - Schmid, K. W. AU - Baba, H. A. PY - 2006 DA - 2006// TI - Overexpression of cyclooxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer but is not associated with protein kinase B (Akt) and mitogen-activated protein kinases (ERK1/2, p38) activation or with Her-2/neu signalling pathways BT - J Clin Pathol ID - Schmitz2006 ER - TY - JOUR AU - Grommes, C. AU - Landreth, G. E. AU - Heneka, M. T. PY - 2004 DA - 2004// TI - Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists JO - Lancet Oncol VL - 5 UR - https://doi.org/10.1016/S1470-2045(04)01509-8 DO - 10.1016/S1470-2045(04)01509-8 ID - Grommes2004 ER - TY - JOUR AU - Koeffler, H. P. PY - 2003 DA - 2003// TI - Peroxisome proliferator-activated receptor gamma and cancers JO - Clin Cancer Res VL - 9 ID - Koeffler2003 ER - TY - JOUR AU - Mueller, E. AU - Sarraf, P. AU - Tontonoz, P. AU - Evans, R. M. AU - Martin, K. J. AU - Zhang, M. AU - Fletcher, C. AU - Singer, S. AU - Spiegelman, B. M. PY - 1998 DA - 1998// TI - Terminal differentiation of human breast cancer through PPAR gamma JO - Mol Cell VL - 1 UR - https://doi.org/10.1016/S1097-2765(00)80047-7 DO - 10.1016/S1097-2765(00)80047-7 ID - Mueller1998 ER - TY - JOUR AU - Burstein, H. J. AU - Demetri, G. D. AU - Mueller, E. AU - Sarraf, P. AU - Spiegelman, B. M. AU - Winer, E. P. PY - 2003 DA - 2003// TI - Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study JO - Breast Cancer Res Treat VL - 79 UR - https://doi.org/10.1023/A:1024038127156 DO - 10.1023/A:1024038127156 ID - Burstein2003 ER - TY - JOUR AU - Spiegelman, B. M. PY - 1998 DA - 1998// TI - PPAR-gamma: adipogenic regulator and thiazolidinedione receptor JO - Diabetes VL - 47 UR - https://doi.org/10.2337/diabetes.47.4.507 DO - 10.2337/diabetes.47.4.507 ID - Spiegelman1998 ER - TY - JOUR AU - Suzuki, T. AU - Hayashi, S. AU - Miki, Y. AU - Nakamura, Y. AU - Moriya, T. AU - Sugawara, A. AU - Ishida, T. AU - Ohuchi, N. AU - Sasano, H. PY - 2006 DA - 2006// TI - Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01075 DO - 10.1677/erc.1.01075 ID - Suzuki2006 ER - TY - JOUR AU - Pignatelli, M. AU - Cortes-Canteli, M. AU - Lai, C. AU - Santos, A. AU - Perez-Castillo, A. PY - 2001 DA - 2001// TI - The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells JO - J Cell Sci VL - 114 ID - Pignatelli2001 ER - TY - JOUR AU - Demetri, G. D. AU - Fletcher, C. D. AU - Mueller, E. AU - Sarraf, P. AU - Naujoks, R. AU - Campbell, N. AU - Spiegelman, B. M. AU - Singer, S. PY - 1999 DA - 1999// TI - Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma JO - Proc Natl Acad Sci U S A VL - 96 UR - https://doi.org/10.1073/pnas.96.7.3951 DO - 10.1073/pnas.96.7.3951 ID - Demetri1999 ER - TY - JOUR AU - Elstner, E. AU - Muller, C. AU - Koshizuka, K. AU - Williamson, E. A. AU - Park, D. AU - Asou, H. AU - Shintaku, P. AU - Said, J. W. AU - Heber, D. AU - Koeffler, H. P. PY - 1998 DA - 1998// TI - Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.15.8806 DO - 10.1073/pnas.95.15.8806 ID - Elstner1998 ER - TY - JOUR AU - Badawi, A. F. AU - Badr, M. Z. PY - 2003 DA - 2003// TI - Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis JO - Int J Cancer VL - 103 UR - https://doi.org/10.1002/ijc.10770 DO - 10.1002/ijc.10770 ID - Badawi2003 ER - TY - JOUR AU - Jiang, W. G. AU - Redfern, A. AU - Bryce, R. P. AU - Mansel, R. E. PY - 2000 DA - 2000// TI - Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells JO - Prostaglandins Leukot Essent Fatty Acids VL - 62 UR - https://doi.org/10.1054/plef.1999.0131 DO - 10.1054/plef.1999.0131 ID - Jiang2000 ER - TY - JOUR AU - Yoshimura, N. AU - Sano, H. AU - Okamoto, M. AU - Akioka, K. AU - Ushigome, H. AU - Kadotani, Y. AU - Yoshimura, R. AU - Nobori, S. AU - Higuchi, A. AU - Ohmori, Y. AU - Nakamura, K. PY - 2003 DA - 2003// TI - Expression of cyclooxygenase-1 and -2 in human breast cancer JO - Surg Today VL - 33 UR - https://doi.org/10.1007/s00595-003-2606-3 DO - 10.1007/s00595-003-2606-3 ID - Yoshimura2003 ER - TY - JOUR AU - Watanabe, O. AU - Shimizu, T. AU - Imamura, H. AU - Kinoshita, J. AU - Utada, Y. AU - Okabe, T. AU - Kimura, K. AU - Hirano, A. AU - Yoshimatsu, K. AU - Aiba, M. AU - Ogawa, K. PY - 2003 DA - 2003// TI - Expression of cyclooxygenase-2 in malignant and benign breast tumors JO - Anticancer Res VL - 23 ID - Watanabe2003 ER - TY - JOUR AU - Schrey, M. P. AU - Patel, K. V. PY - 1995 DA - 1995// TI - Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators JO - Br J Cancer VL - 72 UR - https://doi.org/10.1038/bjc.1995.523 DO - 10.1038/bjc.1995.523 ID - Schrey1995 ER - TY - JOUR AU - Vargas, C. AU - Kestin, L. AU - Go, N. AU - Krauss, D. AU - Chen, P. AU - Goldstein, N. AU - Martinez, A. AU - Vicini, F. A. PY - 2005 DA - 2005// TI - Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy JO - Int J Radiat Oncol Biol Phys VL - 63 UR - https://doi.org/10.1016/j.ijrobp.2005.04.045 DO - 10.1016/j.ijrobp.2005.04.045 ID - Vargas2005 ER - TY - JOUR AU - Cornfield, D. B. AU - Palazzo, J. P. AU - Schwartz, G. F. AU - Goonewardene, S. A. AU - Kovatich, A. J. AU - Chervoneva, I. AU - Hyslop, T. AU - Schwarting, R. PY - 2004 DA - 2004// TI - The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone JO - Cancer VL - 100 UR - https://doi.org/10.1002/cncr.20260 DO - 10.1002/cncr.20260 ID - Cornfield2004 ER - TY - JOUR AU - Livasy, C. A. AU - Perou, C. M. AU - Karaca, G. AU - Cowan, D. W. AU - Maia, D. AU - Jackson, S. AU - Tse, C. K. AU - Nyante, S. AU - Millikan, R. C. PY - 2007 DA - 2007// TI - Identification of a basal-like subtype of breast ductal carcinoma in situ JO - Hum Pathol VL - 38 UR - https://doi.org/10.1016/j.humpath.2006.08.017 DO - 10.1016/j.humpath.2006.08.017 ID - Livasy2007 ER - TY - JOUR AU - Ringberg, A. AU - Anagnostaki, L. AU - Anderson, H. AU - Idvall, I. AU - Ferno, M. PY - 2001 DA - 2001// TI - Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00165-4 DO - 10.1016/S0959-8049(01)00165-4 ID - Ringberg2001 ER - TY - JOUR AU - Fisher, B. AU - Dignam, J. AU - Wolmark, N. AU - Mamounas, E. AU - Costantino, J. AU - Poller, W. AU - Fisher, E. R. AU - Wickerham, D. L. AU - Deutsch, M. AU - Margolese, R. AU - Dimitrov, N. AU - Kavanah, M. PY - 1998 DA - 1998// TI - Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17 JO - J Clin Oncol VL - 16 ID - Fisher1998 ER - TY - JOUR AU - Collins, L. C. AU - Rubin, M. A. AU - Schnitt, S. J. PY - 2004 DA - 2004// TI - Are tissue microarrays useful for the study of pre-invasive breast lesions? JO - Breast Cancer Res Treat VL - 88 ID - Collins2004 ER - TY - JOUR AU - Yang, X. R. AU - Charette, L. A. AU - Garcia-Closas, M. AU - Lissowska, J. AU - Paal, E. AU - Sidawy, M. AU - Hewitt, S. M. AU - Rimm, D. L. AU - Sherman, M. E. PY - 2006 DA - 2006// TI - Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma JO - Diagn Mol Pathol VL - 15 UR - https://doi.org/10.1097/01.pdm.0000213453.45398.e0 DO - 10.1097/01.pdm.0000213453.45398.e0 ID - Yang2006 ER - TY - JOUR AU - Jirstrom, K. AU - Ringberg, A. AU - Ferno, M. AU - Anagnostaki, L. AU - Landberg, G. PY - 2003 DA - 2003// TI - Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence JO - Br J Cancer VL - 89 UR - https://doi.org/10.1038/sj.bjc.6601398 DO - 10.1038/sj.bjc.6601398 ID - Jirstrom2003 ER - TY - JOUR AU - Barnes, N. L. AU - Khavari, S. AU - Boland, G. P. AU - Cramer, A. AU - Knox, W. F. AU - Bundred, N. J. PY - 2005 DA - 2005// TI - Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1633 DO - 10.1158/1078-0432.CCR-04-1633 ID - Barnes2005 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/8/36/prepub UR - http://www.biomedcentral.com/1471-2407/8/36/prepub ID - ref66 ER -